Get started
Author

Yaoge Jiao

Observed name: 四川大学华西医院 生物治疗国家重点实验室, 生物治疗研究室, 肿瘤中心, 四川, 成都市 610041, 中国
OpenAlex ID: A5029998500
Bi-PE: bi-directional priming improves CRISPR/Cas9 prime editing in mammalian cells
2022 · Rui Tao, Yanhong Wang, et al. · Nucleic Acids Research · 82
HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
2022 · Nan Liu, Lifang Zhou, et al. · Molecular Therapy — Nucleic Acids · 58
WT-PE: Prime editing with nuclease wild-type Cas9 enables versatile large-scale genome editing
2022 · Rui Tao, Yanhong Wang, et al. · Signal Transduction and Targeted Therapy · 57
PDF
A universal strategy for AAV delivery of base editors to correct genetic point mutations in neonatal PKU mice
2022 · Lifang Zhou, Jing Su, et al. · Molecular Therapy — Methods & Clinical Development · 24
Targeted, programmable, and precise tandem duplication in the mammalian genome
2023 · Yaoge Jiao, Min Li, et al. · Genome Research · 14
PDF
Glucocorticoid pre-administration improves LNP-mRNA mediated protein replacement and genome editing therapies
2025 · Li Li, Mei Luo, et al. · International Journal of Pharmaceutics · 11
Expanding PAM recognition and enhancing base editing activity of Cas9 variants with non‐PI domain mutations derived from xCas9
2022 · Lifang Xie, Yun Hu, et al. · FEBS Journal · 8
Random-PE: an efficient integration of random sequences into mammalian genome by prime editing
2021 · Yaoge Jiao, Lifang Zhou, et al. · Molecular Biomedicine · 8
PDF
Harnessing nucleotide metabolism to control glycosylase base editing outcomes
2026 · Rui Tao, Min Li, et al. · Theranostics · 3
PDF
HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
2022 · Nan Liu, Lifang Zhou, et al. · Molecular Therapy — Nucleic Acids · 1
Reporter-based screening identifies small-molecule CBL0137 as an enhancer of CRISPR cytosine base editor and prime editor via p53 activation and NF-κB inhibition
2026 · Yun Hu, Yanhong Wang, et al. · New Biotechnology
优化的gGBE在哺乳动物细胞和斑马鱼胚胎中实现高效G-to-Y转换
2026 · Li Min, 四川大学华西医院 生物治疗国家重点实验室, 生物治疗研究室, 肿瘤中心, 四川, 成都市 610041, 中国, et al. · 动物学研究
PDF
Author response for "Expanding PAM recognition and enhancing base editing activity of Cas9 variants with non‐PI domain mutations derived from xCas9"
2022 · Lifang Xie, Yun Hu, et al.
Author response for "Expanding PAM recognition and enhancing base editing activity of Cas9 variants with non‐PI domain mutations derived from xCas9"
2022 · Lifang Xie, Yun Hu, et al.
Works count: 14
Citation count: 266
H-index: 8
I10-index: 6
Year
Topic
Type